文献速递自身炎症与 IgG4 相关病

多组学技术如何助力定义儿童未分化系统性自身炎症性疾病:欧洲PerSAIDs联盟的经验

How multi-omic technologies can help define paediatric undifferentiated systemic autoinflammatory diseases: the experience of the European PerSAIDs consortium.
PubMed 文献 · RMD Open · 2026-08-19

本文综述多组学技术在儿童未分化系统性自身炎症性疾病(uSAIDs)中的应用前景与挑战。单基因SAIDs已实现精准医学,但无明确遗传病因的uSAIDs仍缺乏个体化诊疗手段。多组学整合基因组学、转录组学、蛋白质组学等可识别疾病特异性生物标志物,但样本采集、方法标准化和生物信息学工具开发仍是临床转化的主要障碍。

要点

  • 单基因SAIDs已实现精准医学,uSAIDs因无明确遗传病因仍缺乏个体化诊疗。
  • 多组学整合有望识别uSAIDs的疾病特异性生物标志物或复杂分子模式。
  • 样本采集、方法标准化和生物信息学工具开发是临床转化的主要挑战。

核心结论

  • 多组学方法有望推动儿童uSAIDs的精准诊断和个体化治疗,但临床转化前仍需解决样本采集、方法标准化和生物信息学工具开发等挑战。

研究设计与样本

  • 本文为综述,介绍欧洲PerSAIDs联盟(ERA PerMed项目)将多组学研究与人工智能决策支持相结合以推进SAIDs诊疗的经验。

主要发现

  • 单基因SAIDs的精准医学已确立,而无明确遗传病因的uSAIDs仍缺乏个体化诊疗策略。
  • 多组学整合基因组学、转录组学、蛋白质组学、表观基因组学和免疫组学等技术,可识别疾病特异性生物标志物或复杂分子模式。
  • 多组学分析在免疫介导疾病中已有成功应用案例。

临床怎么用

  • 多组学与人工智能决策支持结合的模式可能为儿童uSAIDs的诊断和管理提供新路径,但目前尚处于研究阶段,尚未转化为临床实践。

局限性

  • 患者样本采集、方法学标准化和稳健生物信息学工具的开发仍是多组学发现转化为临床实践前的主要挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Systemic AutoInflammatory Diseases (SAIDs) are rare conditions characterised by impaired control of inflammatory and innate immune responses. Precision medicine is already well established for monogenic SAIDs, while personalised approaches remain elusive for those conditions with not identified genetic cause, collectively named undifferentiated SAIDs (uSAIDs).The multi-omic approach integrates findings from various 'omics'" technologies (eg, genomics, transcriptomics, proteomics, epigenomics, immunomics), thus representing a potential way of identifying disease-specific biomarkers or complex molecular patterns, offering significant improvements in diagnosis and personalised therapies. At present, significant challenges remain in patient's sample collection, methodological standardisation and the development of robust bioinformatics tools before the findings can be translated into clinical practice. We provide examples of successful applications of multi-omic analyses to immune-mediated disorders, address the challenges and opportunities associated with multi-omics in paediatric uSAIDs and introduce the ERA PerMed project 'PerSAIDs', which combines multi-omic research with artificial intelligence-based decision support solutions to further advance the diagnosis and management of SAIDs.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Speziani C, Palmeri S, Uva P, et al. How multi-omic technologies can help define paediatric undifferentiated systemic autoinflammatory diseases: the experience of the European PerSAIDs consortium. RMD Open. 2026. PMID: 42618213. doi:10.1136/rmdopen-2026-006855

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。